Drawing for GENEXINE

USPTO serial 79164375

GENEXINE

Reviewed by CopyMark Law Group

Reg. 4806220Status 706Registered
Filing date
Status date
Registration date
Sep 8, 2015
Examiner
LEASER, ANDREW C
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with GENEXINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LEIGH ANN LINDQUIST

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
042Research and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; research on cancer; pharmaceutical products development; pharmaceutical products research; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical product testing; research for medical products; medical research; clinical trials; research and development of DNA chips; structural and functional analysis of genomes; biotechnology research; advisory services relating to biotechnology; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; testing/inspection or research on pharmaceuticals/cosmetics or foodACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 20, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 20, 202571AGREGISTERED-SEC.71 ACCEPTED—
Mar 17, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 19, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 28, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 25, 2024ES71TEAS SECTION 71 RECEIVED—
Sep 8, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Feb 3, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 3, 202171AGREGISTERED-SEC.71 ACCEPTED—
Feb 1, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 30, 2020ES71TEAS SECTION 71 RECEIVED—
May 28, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 4, 2015GPNXNOTIFICATION PROCESSED BY IB—
Nov 16, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 16, 2015FIMPFINAL DISPOSITION PROCESSED—
Oct 8, 2015GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Sep 8, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 26, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 23, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2015NPUBNOTICE OF PUBLICATION—
May 14, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 9, 2015DOCKASSIGNED TO EXAMINER—
May 9, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance